NCT05950503 Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
| NCT ID | NCT05950503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-07-10 |
| Primary Completion | 2026-06-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-07-10 with a primary completion date of 2026-06-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years; * Histological diagnosis of colorectal cancer; * Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG); * At least one measurable liver lesion according to RECIST 1.1 criteria; * Adequate organ and marrow function. Exclusion Criteria: * Age \< 18 years; * Inability to undergo MRI; * Major contraindications to liver surgery; * No written informed consent.
Contact & Investigator
Lisa Salvatore, MD, PhD
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT05950503 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05950503 currently recruiting?
Yes, NCT05950503 is actively recruiting participants. Contact the research team at lisa.salvatore@policlinicogemelli.it for enrollment information.
Where is the NCT05950503 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT05950503 clinical trial?
NCT05950503 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Lisa Salvatore, MD, PhD at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.